Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.
BACKGROUND
Prostaglandin E2 (PGE2) is involved in several chronic inflammatory diseases including periodontitis, which causes loss of the gingival tissue and alveolar bone supporting the teeth. We have previously shown that tumor necrosis factor alpha (TNFalpha) induces PGE2 synthesis in gingival fibroblasts. In this study we aimed to investigate the global gene expression profile of TNFalpha-stimulated primary human gingival fibroblasts, focusing on signal pathways related to the PGE2-synthesizing enzymes prostaglandin E synthases (PGES), as well as the upstream enzyme cyclooxygenase-2 (COX-2) and PGE2 production.


RESULTS
Microarray and western blot analyses showed that the mRNA and protein expression of the inflammatory induced microsomal prostaglandin E synthase-1 (mPGES-1) was up-regulated by the cytokine TNFalpha, accompanied by enhanced expression of COX-2 and increased production of PGE2. In contrast, the expression of the isoenzymes microsomal prostaglandin E synthase-2 (mPGES-2) and cytosolic prostaglandin E synthase (cPGES) was unaffected by TNFalpha treatment. Using oligonucleotide microarray analysis in a time-course factorial design including time points 1, 3 and 6 h, differentially expressed genes in response to TNFalpha treatment were identified. Enrichment analysis of microarray data indicated two positively regulated signal transduction pathways: c-Jun N-terminal kinase (JNK) and Nuclear Factor-kappaB (NF-kappaB). To evaluate their involvement in the regulation of mPGES-1 and COX-2 expression, we used specific inhibitors as well as phosphorylation analysis. Phosphorylation analysis of JNK (T183/Y185) and NF-kappaB p65 (S536) showed increased phosphorylation in response to TNFalpha treatment, which was decreased by specific inhibitors of JNK (SP600125) and NF-kappaB (Bay 11-7082, Ro 106-9920). Inhibitors of JNK and NF-kappaB also decreased the TNFalpha-stimulated up-regulation of mPGES-1 and COX-2 as well as PGE2 production.


CONCLUSIONS
In the global gene expression profile, the enrichment analysis of microarray data identified the two signal transduction pathways JNK and NF-kappaB as positively regulated by the cytokine TNFalpha. Inhibition of these TNFalpha-activated signal pathways reduced the expression of mPGES-1 and COX-2 as well as their end product PGE2 in gingival fibroblasts. The involvement of the signal pathways JNK and NF-kappaB in the regulation of PGE2 induced by TNFalpha may suggest these two pathways as possible attractive targets in the chronic inflammatory disease periodontitis.
Båge
Tove
T
Division of Pediatric Dentistry, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden. tove.bage@ki.se
Lindberg
Johan
J
Lundeberg
Joakim
J
Modéer
Thomas
T
Yucel-Lindberg
Tülay
T
D051546:Cyclooxygenase 2 / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism*; D020869:Gene Expression Profiling; D005881:Gingiva / Q000378:metabolism*; D006801:Humans; D019746:Intramolecular Oxidoreductases / Q000378:metabolism*; D052002:NF-kappa B p50 Subunit / Q000378:metabolism*; D000071876:Prostaglandin-E Synthases; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D052002:NF-kappa B p50 Subunit; C489548:NFKB1 protein, human; D014409:Tumor Necrosis Factor-alpha; D051546:Cyclooxygenase 2; D019746:Intramolecular Oxidoreductases; C000605862:PTGES protein, human; C000605863:PTGES2 protein, human; D000071876:Prostaglandin-E Synthases
J Biol Chem. 2004 May 21;279(21):22057-65
15023995
Exp Eye Res. 2007 Aug;85(2):280-8
17604021
Lab Invest. 2005 Feb;85(2):225-36
15531909
Naunyn Schmiedebergs Arch Pharmacol. 2009 Aug;380(2):153-60
19415240
Nucleic Acids Res. 2007 Jan;35(Database issue):D760-5
17099226
Nucleic Acids Res. 2007 Jan;35(Database issue):D26-31
17148475
Inflammation. 2004 Apr;28(2):89-95
15379214
J Biol Chem. 1997 Aug 22;272(34):21096-103
9261113
J Periodontal Res. 2003 Apr;38(2):198-203
12608915
Biochim Biophys Acta. 1999 Aug 18;1439(3):406-14
10446427
J Immunol. 2009 Aug 15;183(4):2767-74
19625654
J Periodontal Res. 1983 Mar;18(2):156-63
6223995
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7220-5
10377395
Am J Physiol Cell Physiol. 2005 Nov;289(5):C1229-39
15972838
Biochem Biophys Res Commun. 1997 Jun 9;235(1):148-52
9196052
Biochem Biophys Res Commun. 1999 Nov 2;264(3):865-70
10544022
Arthritis Res Ther. 2004;6(4):R355-65
15225371
Arthritis Rheum. 2004 Feb;50(2):420-31
14872484
Mediators Inflamm. 2005 Oct 24;2005(5):249-55
16258191
J Pharmacol Exp Ther. 2005 Nov;315(2):788-95
16081677
J Periodontol. 2008 Mar;79(3):477-85
18315430
Proc Assoc Am Physicians. 1999 Nov-Dec;111(6):516-24
10591080
Mol Pharmacol. 2001 Mar;59(3):493-500
11179444
J Clin Invest. 2001 Jul;108(1):73-81
11435459
J Biol Chem. 2004 Mar 26;279(13):12647-58
14722058
J Periodontal Res. 1994 Mar;29(2):118-26
8158500
Int J Cancer. 2003 Nov 20;107(4):551-6
14520691
J Biol Chem. 2002 May 10;277(19):16355-64
11847219
Biochemistry. 2005 Jun 14;44(23):8326-36
15938622
J Immunol. 1998 Jan 1;160(1):403-9
9551997
Bioinformatics. 2007 Jan 15;23(2):257-8
17098774
J Periodontol. 1989 Sep;60(9):485-90
2677301
J Periodontol. 2009 May;80(5):833-49
19405838
J Periodontol. 2008 Sep;79(9):1645-51
18771364
Periodontol 2000. 1997 Jun;14:33-53
9567965
Quintessence Int. 2005 Apr;36(4):299-306
15835427
Int Immunopharmacol. 2006 Jun;6(6):987-96
16644485
Med Hypotheses. 2009 Sep;73(3):457-8
19464122
Clin Immunol. 2006 Jun;119(3):229-40
16540375
Bioinformatics. 2003 Feb 12;19(3):368-75
12584122
J Biol Chem. 2000 Oct 20;275(42):32775-82
10922363
Nat Genet. 2000 May;25(1):25-9
10802651
J Immunol. 2001 Jul 1;167(1):469-74
11418684
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13681-6
11717429
J Biol Chem. 2000 Oct 20;275(42):32783-92
10869354
J Dent. 1998 Mar;26(2):97-103
9540305
Nucleic Acids Res. 2002 Feb 15;30(4):e15
11842121
Periodontol 2000. 1997 Jun;14:216-48
9567973
J Cell Physiol. 2003 Dec;197(3):348-56
14566964
Physiol Genomics. 2007 Oct 22;31(2):343-51
17652167
Arthritis Rheum. 2002 Mar;46(3):818-23
11920420
J Periodontal Res. 1991 Sep;26(5):415-21
1832454
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:115-28
12432913
J Clin Periodontol. 2002 Jan;29(1):15-20
11846844
Br J Pharmacol. 2008 Mar;153 Suppl 1:S241-6
17965753
Cell Physiol Biochem. 2006;17(1-2):69-78
16543723
BMC Med Genomics. 2008 Jul 07;1:30
18606014
Biochem Biophys Res Commun. 2002 Mar 8;291(4):884-9
11866447
J Periodontol. 2003 Mar;74(3):391-401
12710761
Periodontol 2000. 2007;43:85-101
17214837
Lancet. 2005 Nov 19;366(9499):1809-20
16298220
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H165-74
15358613
Genome Biol. 2004;5(10):R80
15461798
J Pharmacol Exp Ther. 1999 Oct;291(1):124-30
10490895
Periodontol 2000. 1997 Jun;14:144-57
9567969
Eur J Oral Sci. 2004 Jun;112(3):216-23
15154918
J Biol Chem. 2006 Jun 16;281(24):16443-52
16627484
FEBS Lett. 2003 Jul 17;547(1-3):75-9
12860389
J Leukoc Biol. 2005 Mar;77(3):388-99
15591425
J Biol Chem. 2002 Jun 28;277(26):23573-81
11950839
Biochim Biophys Acta. 2007 Oct;1773(10):1589-98
17707523
J Dent Res. 1999 Jan;78(1):61-8
10065947
Cell Signal. 2006 Dec;18(12):2131-42
16766159
J Allergy Clin Immunol. 1978 Aug;62(2):96-102
97337
Int J Mol Med. 2006 Mar;17(3):449-55
16465391
Arthritis Res Ther. 2006;8(2):R47
16507157
J Clin Periodontol. 2005 Jan;32(1):6-11
15642051
Biochem Biophys Res Commun. 2003 Jun 13;305(4):970-3
12767925
Biostatistics. 2004 Jan;5(1):89-111
14744830
Sci STKE. 2006 Oct 17;2006(357):re13
17047224
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Curr Drug Metab. 2007 Dec;8(8):750-7
18220555
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:383-99
12432931
Infect Immun. 1987 Sep;55(9):2148-54
3040590
BMC Genomics. 2005 Sep 28;6:137
16191192
J Immunol. 2001 Oct 1;167(7):3962-71
11564815
J Rheumatol. 2006 Dec;33(12):2398-408
17225293
Nucleic Acids Res. 2002 Jan 1;30(1):169-71
11752283